Bayesian Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-8,420
Closed -$232K 807
2017
Q4
$232K Buy
+8,420
New +$223K 0.05% 472
2016
Q4
Sell
-10,725
Closed -$243K 701
2016
Q3
$243K Buy
+10,725
New +$234K 0.16% 239
2016
Q2
Sell
-8,900
Closed -$233K 544
2016
Q1
$233K Buy
8,900
+900
+11% +$20.8K 0.22% 235
2015
Q4
$206K Buy
+8,000
New +$216K 0.3% 169

Other funds holding TBI

Bayesian Capital Management's TBI Position: Q1 2018 in Review

Bayesian Capital Management sold out of Trueblue (TBI) in Q1 2018, closing a stake of 8,420 shares — an estimated $232K sold.

Bayesian Capital Management first reported a position in TBI in Q4 2015 and held it in 4 quarters. The position peaked at $243K in Q3 2016. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.

  • Bayesian Capital Management reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 8,420 Trueblue shares in Q1 2018, an estimated $232K.
  • Bayesian Capital Management first reported a position in Trueblue in Q4 2015 and held it in 4 quarters.
  • Bayesian Capital Management's Trueblue position peaked at $243K in Q3 2016.
  • 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.

Based on Bayesian Capital Management's 13F filing for Q1 2018, filed 15 May 2018.